EN
Edward Nash Canaccord Genuity Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
22
Avg Return
Past Year
Past Year
3.4%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
83.3%
Neutral
16.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Maintained
| $3 |
126%
upside
| 1 | – |
–
| 13 Mar ‘26 1 month ago |
|
|
|
Buy
Initiated
| $62 |
38%
upside
| 1 | +4.8% |
0
%
| 19 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $100 |
117%
upside
| 6 | -13% |
0
%
| 23 Jan ‘26 2 months ago |
|
|
|
Hold
Downgraded
| $14 |
0%
upside
| 2 | +48% |
0
%
| 8 Jan ‘26 3 months ago |
|
|
|
Buy
Initiated
| $25 |
925%
upside
| 1 | +8.1% |
0
%
| 18 Dec ‘25 4 months ago |
|
|
|
Buy
Maintained
| $587 |
10%
upside
| 4 | +9.7% |
0
%
| 13 Nov ‘25 5 months ago |
|
|
|
Buy
Maintained
| $107 |
204%
upside
| 2 | +2.5% |
0
%
| 12 Nov ‘25 5 months ago |
|
|
|
Hold
Downgraded
| $54 |
1%
downside
| 1 | -10% |
–
| 9 Oct ‘25 6 months ago |
|
|
|
Buy
Maintained
| $28 |
333%
upside
| 2 | -27% |
0
%
| 2 Oct ‘25 6 months ago |
|
|
|
Buy
Maintained
| $20 |
253%
upside
| 1 | +2.4% |
0
%
| 30 Sep ‘25 6 months ago |
|
|
|
Buy
Maintained
| $62 |
79%
upside
| 3 | +16% |
0
%
| 17 Sep ‘25 7 months ago |
|
|
|
Hold
Downgraded
| $107 |
0%
upside
| 1 | +46% |
–
| 9 Jul ‘25 9 months ago |
|